About

PASSIONATE....

There are no better three words to describe the team we have assembled at Liberty Diagnostics.

Everyone on our staff, top to bottom, believes in our mission that our success depends on the success of our customers. It is why we place you at the forefront every decision made, and why we have a deep-rooted drive to provide exemplary support to your practice.

PROGRESSIVE....

Liberty Diagnostics was founded and built from a group of individuals with an extensive mix of experience in clinical chemistry, marketing, and law.

Possessing this diverse skill set gives us the capacity to solve problems from many angles. The result? A unique package of solutions that are meaningful, useful, and will make a significant difference in standard of care.

INNOVATIVE....

We strive to set the highest bar in the industry by providing the most innovative array of services and resources to our clients.

This innovation is undeniable with the introduction of the Liberty RxTargetSM Pharmacogenetics System. We are so proud to offer a diagnostic tool that no doubt in our mind will improve your patient outcomes and lead to safer prescribing.


State of the Art Laboratory

Sophisticated and complex, our laboratory facilities make use of truly impressive equipment, such as LC/MS/MS (Liquid Chromatography/Mass Spectrometry) and multiplexed PCR (Polymerase Chain Reaction) systems.

LC/MS/MS is quickly becoming the gold standard for performing drug confrimational testing. It allows us to perform a multi-drug class analyses with shorter turnaround times and allows for lower drug detection limits than any equipment available. The power of LC/MS/MS is also its great flexibility in adding on NEW emerging illicit drug classes such as K2/Spice & Bath Salts included in our comprehensive panel.

The driving force behind the RxTarget Pharmacogenetics System is the multiplexed PCR (Polymerase Chain Reaction). Multiplexed PCRs allow us to test for an increased number of genetic abnormalities in the target genes. This means we are able to capture a broader population of genotypes they may lead to metabolic irregularities in your patients.